# Peripheral blood mononuclear cell specimens

Source: https://onco.cc/terms/pbmc-specimens/  
OnCo record `pbmc-specimens` (Term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

This blood-cell preparation contains lymphocytes and monocytes used in many immune tests. Collection and handling affect which cells and responses can be measured.

## Summary

The National Library of Medicine distinguishes mononuclear leukocytes from granulocytes and from monocytes alone. A primary study of immune monitoring in HIV vaccine research found that processing and cryopreservation conditions affected cell recovery, viability and measured antigen responses. Those were assay findings, not a validated cancer-treatment predictor. A blood preparation also samples a different compartment from a tumor biopsy; the specimen and handling conditions belong with its interpretation.

## Fields

- Kind: Term
- Last checked: 2026-11-10
- Also known as: PBMC; PBMCs; peripheral blood mononuclear cells

## Notes

- What the fraction is: peripheral blood mononuclear cells are circulating white blood cells with a single unsegmented nucleus, mainly lymphocytes and monocytes, with T, B and natural killer cells among them, isolated by layering anticoagulated blood over a density-separation medium and collecting the interface. Most conventional granulocytes and red cells separate elsewhere, but recovery is incomplete, so platelets, red cells or low-density granulocytes can contaminate a preparation, and the label PBMC does not guarantee purity. The classic density-gradient method dates from 1968 (Boyum 1968). Isolation selects a recoverable blood fraction and does not sample tumour or give a complete immune census.
- Handling is evidence: in HIV vaccine assay studies, the time from venipuncture to cryopreservation was the most important parameter, and blood processed at 24 hours compared with within 8 hours lost on average about 8% of PBMC viability, about 32% of cell recovery and 36% to 56% of interferon gamma T-cell frequencies by ELISpot, which led the authors to recommend cryopreservation within 8 hours (Bull 2007). That is a finding for those protocols and assays and is not a universal schedule for cancer assays. A rapidly processed baseline and a delayed follow-up can therefore confound a biological comparison, and a high viability percentage alone does not show that every population or function was preserved.
- Preparation card: input is anticoagulated blood or a blood-cell collection product and separation processes that aliquot and retains a selected cell fraction for compatible downstream assays. Output is recovered cell number, viable-cell percentage, recovery after thawing and measured population fractions, with cells per original blood volume needing a documented calculation. Controls are collection and processing timestamps, anticoagulant, storage, counting and viability methods and matched handling across time points. Thresholds are acceptance rules set for the intended downstream assay and not one universal quality number. Fictional case: two tubes have equally high viability but one recovered far fewer monocytes, so they are not automatically interchangeable for a whole-protein stimulation assay, because monocytes can contribute antigen presentation and viability does not show composition.
- The usable input for a downstream assay is the recovered viable cell preparation, not simply the volume of blood drawn. Fresh isolation, freezing, thawing, washing and any rest period define a sequence of selections, so record recovery, population composition and purity as well as viability. The Cytiva density-separation handbook describes the mononuclear interface, platelet carryover and possible immature-granulocyte contamination in pathological blood. That manufacturer method source does not validate every cancer assay, and an inadequate number of the relevant cells can make a rare-response experiment uninformative.
- A stored PBMC sample is a finite specimen. It does not establish immune infiltration of a tumour, preserve every function or population equally, identify antigen specificity, or guarantee enough material for every later test. In the fictional equal-viability comparison, losing monocytes can affect a whole-protein stimulation because antigen-presenting-cell composition matters; viability alone does not establish interchangeable inputs. Fit and acceptance rules belong to the intended downstream assay.

## Sources

- NLM MeSH: mononuclear leukocytes, definition: https://id.nlm.nih.gov/mesh/M0012412.json
- Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials.: https://doi.org/10.1016/j.jim.2007.02.003
- Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.: https://pubmed.ncbi.nlm.nih.gov/4179068/
- Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials.: https://pubmed.ncbi.nlm.nih.gov/17382342/
- Cossarizza et al.: flow cytometry and cell sorting guidelines, third edition (2021): https://doi.org/10.1002/eji.202170126
- Cytiva: isolation of mononuclear cells, separation principle and pathological blood specimens: https://cdn.cytivalifesciences.com/api/public/content/digi-16156-pdf

## Connected records

- terms: [ELISpot secretion assays](https://onco.cc/terms/elispot/), [Flow cytometry (immunophenotyping)](https://onco.cc/terms/flow-cytometry/), [Immune measurements and product evidence](https://onco.cc/terms/immune-product-evidence/), [Intracellular cytokine staining](https://onco.cc/terms/intracellular-cytokine-staining/), [T-cell receptor repertoire sequencing](https://onco.cc/terms/tcr-repertoire-sequencing/), [Tissue preparation and assay suitability](https://onco.cc/terms/tissue-preparation-assay-fit/)
- technologies: [Pre-analytics: blood-collection tubes and tissue fixation](https://onco.cc/technologies/preanalytics-sample-stabilisation/)

---
JSON: https://onco.cc/api/v1/entities/pbmc-specimens.json